<DOC>
	<DOC>NCT01964105</DOC>
	<brief_summary>The purpose of this trial is to evaluate the impact of incorporating three-dimensional (3D)imaging during preoperative consultation on patient reported outcomes in primary breast augmentation surgery. 3D imaging is an innovative technology that allows the surgeon to share with images how one could look after one's procedure. The patient's assessment will be collected using the Breast Q, an objective questionnaire that captures patient satisfaction with breast augmentation.</brief_summary>
	<brief_title>3D Breast Imaging for Cosmetic and Reconstructive Breast Surgery</brief_title>
	<detailed_description />
	<criteria>Age 18 years or older Scheduled for elective breast augmentation cosmetic procedure. Breast reconstruction for malignancy Cognitively unable to provide informed consent.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Hypomastia</keyword>
	<keyword>Augmentation</keyword>
	<keyword>Breast</keyword>
	<keyword>3D</keyword>
	<keyword>Breast Q</keyword>
</DOC>